News

Adding to the Medtronic portfolio of catheter-based lead solutions, the novel OmniaSecure defibrillation lead allows for precise delivery and placement in the right ventricle

Omny-IRE data demonstrated the investigational OMNYPULSE™ Platform achieved 100% acute success and 84.5% pulmonary vein isolation (PVI) durability at three months, with promising safety outcomes1

New investment fuels growth of ECG-AI platform and development of perioperative AI capabilities

Trial achieves positive results in the treatment of persistent atrial fibrillation

Comprehensive analysis of real-world data shows significant clinical and medico-economic advantages of Implicity's universal, alert-based remote monitoring platform

The Heart Rhythm Society (HRS) unveiled new research that underscores the critical role of artificial intelligence (AI) in improving procedural safety in cardiac electrophysiology (EP), demonstrating how intelligent, real-time decision...

Rampart IC, a medical technology company developing market-leading radiation safety and orthopedic protection solutions for the interventional suite, announced the successful completion of its $21.6M Series B financing round. The round was...

This document draws on global clinical data and real-world evidence to evaluate the impact of a cardiac ablation SDD strategy on patient safety, access, operational efficiencies, and healthcare costs. It also outlines best practices based on...

IMPRoVED AF RCT and VITAL-EP Registry Reinforce Vektor’s Focus on Data That Drives EP Adoption and Ablation Outcomes

BRITE-MOM study uses Vivalink's wearable devices and data platform to examine arrhythmias in high-risk pregnancies